Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens

Journal of Peptide Science

Volumn 15, Issue 9, 2009, Pages 595-600

  Benincasa, M ^a   Mattiuzzo, M ^a   Herasimenka, Y ^a   Cescutti, P ^a   Rizzo, R ^a   Gennaro, R ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antimicrobial peptides; Cathelicidins; Cystic fibrosis; Defensins; Lung infection; Polysaccharides; Pulmonary pathogens

Indexed keywords

BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHELICIDIN ANTIMICROBIAL PEPTIDE SMAP 29; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN 1; PROTEIN BAC7[1-35]; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; BURKHOLDERIA CEPACIA; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; BURKHOLDERIA MALLEI; CATHELICIDINS; CELL MEMBRANE; CYSTIC FIBROSIS; DRUG INTERACTIONS; ESCHERICHIA COLI; HUMANS; KINETICS; KLEBSIELLA PNEUMONIAE; LUNG DISEASES; MICROBIAL SENSITIVITY TESTS; POLYSACCHARIDES, BACTERIAL; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA COMPLEX; KLEBSIELLA PNEUMONIAE; MAMMALIA; PSEUDOMONAS AERUGINOSA;

EID: 70349650567     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1142     Document Type: Conference Paper

References (34)

1. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity:more than just microbicidal. Trends Immunol. 2002; 23: 291-296.
2. Pazgier M, Li X, Lu W, Lubkowski J. Human defensins: synthesis and structural properties. Curr. Pharm. Des. 2007; 13: 3096-3118.
3. Tomasinsig L, Scocchi M, Di Loreto C, Artico D, Zanetti M. Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J. Leukoc. Biol. 2002; 72: 1003-1010.
4. Zanetti M, Gennaro R, Skerlavaj B, Tomasinsig L, Circo R. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr. Pharm. Des. 2002; 8: 779-793.
5. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J. Clin. Invest. 2002; 109: 693-697.
6. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 2004; 23: 327-333.
7. Bartlett JA, Fischer AJ, McCray PB Jr. Innate immune functions of the airway epithelium. Contrib. Microbiol. 2008; 15: 147-163.
8. Fahy RJ, Wewers MD. Pulmonary defense and the human cathelicidin hCAP-18/ LL-37. Immunol. Res. 2005; 31: 75-89.
9. Travis SM, Singh PK, Welsh MJ. Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr. Opin. Immunol. 2001; 13: 89-95.
10. Govan JR, Deretic V. Microbialpathogenesis in cystic fibrosis:mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 1996; 60: 539-574.
11. Carpenter JL. Klebsiella pulmonary infections: occurrence at one medical center and review. Rev. Infect. Dis. 1990; 12: 672-682.
12. Trautmann M, Ruhnke M, Rukavina T, Held TK, Cross AS, Marre R, Whitfield C. O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin. Diagn. Lab. Immunol. 1997; 4: 550-555.
13. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001; 9: 34-39.
14. Benincasa M, Scocchi M, Podda E, Skerlavaj B, Dolzani L, Gennaro R. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Peptides 2004; 25: 2055-2061.
15. Skerlavaj B, Benincasa M, Risso A, Zanetti M, Gennaro R. SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett. 1999; 463: 58-62.
16. BenincasaM, Scocchi M, Pacor S, Tossi A, Nobili D, Basaglia G, Busetti M, Gennaro R. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 2006; 58: 950-959.
17. Boniotto M, Antcheva N, Zelezetsky I, Tossi A, Palumbo V, Verga Falzacappa MV, Sgubin S, Braida L, Amoroso A, Crovella S. A study of host defence peptide beta-defensin 3 in primates. Biochem. J. 2003; 374: 707-714.
18. Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A. Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J. Biol. Chem. 2006; 281: 19861-19871.
19. Cescutti P, Toffanin R, Kvam BJ, Paoletti S, Dutton GG. Structural determination of the capsular polysaccharide produced by Klebsiella pneumoniae serotype K40. NMR studies of the oligosaccharide obtained upon depolymerisation of the polysaccharide with a bacteriophage-associate dendoglycanase. Eur. J. Biochem. 1993; 213: 445-453.
20. Cescutti P, Bosco M, Picotti F, Impallomeni G, Leitao JH, Richau JA, Sa-Correia I. Structural study of the exopolysaccharide produced by a clinical isolate of Burkholderia cepacia. Biochem. Biophys. Res. Commun. 2000; 273: 1088-1094.
21. Gennaro R, Scocchi M,Merluzzi L, Zanetti M. Biological characterization of a novel mammalian antimicrobial peptide. Biochim. Biophys. Acta 1998; 1425: 361-368.
22. Herasimenka Y, Benincasa M, Mattiuzzo M, Cescutti P, Gennaro R, Rizzo R. Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 2005; 26: 1127-1132.
23. Steinberg DA, Hurst MA, Fujii CA, Kung AH, Ho JF, Cheng FC, Loury DJ, Fiddes JC. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 1997; 41: 1738-1742.
24. Hiemstra PS. Antimicrobial peptides in the real world: implications for cystic fibrosis. Eur. Respir. J. 2007; 29: 617-618.
25. Bals R, Weiner DJ, Wilson JM. The innate immune system in cystic fibrosis lung disease. J. Clin. Invest. 1999; 103: 303-307.
26. Knowles MR, Robinson JM, Wood RE, Pue CA, Mentz WM, Wager GC, Gatzy JT, Boucher RC. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease control subjects. J. Clin. Invest. 1997; 100: 2588-2595.
27. Weiner DJ, Bucki R, Janmey PA. The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am. J. Respir. Cell Mol. Biol. 2003; 28: 738-745.
28. Chan C, Burrows LL, Deber CM. Helix induction in antimicrobial peptides by alginate in biofilms. J. Biol. Chem. 2004; 279: 38749-38754.
29. Kuo HH, Chan C, Burrows LL, Deber CM. Hydrophobic interactions in complexes of antimicrobial peptides with bacterial polysaccharides. Chem. Biol. Drug Des. 2007; 69: 405-412.
30. Gennaro R, Zanetti M, Benincasa M, Podda E, Miani M. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 2002; 8: 763-778.
31. Fahrner RL, Dieckmann T, Harwig SS, Lehrer RI, Eisenberg D, Feigon J. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 1996; 3: 543-550.
32. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB, Tack BF, Vogel HJ Jr. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 2002; 277: 8279-8289.
33. Dhople V, Krukemeyer A, Ramamoorthy A. The human betadefensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta 2006; 1758: 1499-1512.
34. Matsui H, Wagner VE, Hill DB, Schwab UE, Rogers TD, Button B, Taylor RM, Superfine R, Rubinstein M, Iglewski BH, Boucher RC II. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 18131-18136.